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Dear Editor,
A 66-year-old man was treated for acute myelomono-
cytic leukemia with mitoxantrone, cytarabine, and
etoposide. As it is our practice, we gave him 500 mg
ciprofloxacin every 12 h per os for antibacterial
prophylaxis. Two weeks later, he complained of pain
in both shoulders which worsened until he could no
longer raise his arms. He also had pain in his hips and
knees, but the Achilles tendons were not involved.
There were no signs of inflammation, but palpation of
the insertion point of the supraspinatus tendon proved
painful. Ultrasound examination showed a bilateral
partial rupture of the supraspinatus tendon and sub-
scapularis tendinopathy (Fig. 1). We suspected cipro-
floxacin toxicity so we stopped the drug and he was
given analgesics and physiotherapy. The pain resolved
completely within a few days; however, full functional
recovery took several months. We did not re-challenge
with ciprofloxacin as the side effects had been so
severe.
Antibiotic prophylaxis reduces infections and enhan-
ces survival when given to high-risk patients receiving
chemotherapy for acute leukemia or stem cell transplant.
Current guidelines recommend prophylaxis be given
from the start of chemotherapy until bone marrow
recovery when the expected duration of neutropenia is
more than 7 days [1, 2]. Fluoroquinolones, which provide
a broad antimicrobial spectrum, are generally well
tolerated and have a good safety profile. However, they
can cause tendinitis and other forms of tendon damage in
10–15 per 100,000 prescriptions, a rate that increases with
older age, renal dysfunction, and corticosteroid use. The
onset of symptoms is typically within 2 weeks after
starting treatment, but symptoms can occur within 2 h
after the first dose until 6 months after cessation of
treatment. The Achilles tendon is affected in 90% cases,
almost half involving both ankles and the tendon ruptures
in approximately 50% of the cases. Other sites of tendon
injury have been reported but are rare. Recovery usually
takes 1–2 months requiring rest and immobilization and
surgery is seldom needed [3, 4]. How fluoroquinolones
induce tendon injury is not understood.
Our patient's age appears to have been the only risk
factor as he had not used corticosteroids and did not have
renal dysfunction. In July 2008, the FDA added a black
box warning to alert doctors and patients of the raised risk
of tendinitis and tendon rupture associated with fluoro-
quinolones [5]. As clinicians will be treating an increasing
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DOI 10.1007/s00277-011-1220-5number of elderly patients for hematological malignancies,
it is very important for them to recognize these symptoms
and switch to an alternative treatment before tendon
rupture occurs.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Segal BH, Freifeld AG (2007) Antibacterial prophylaxis in patients
with neutropenia. J Natl Compr Canc Netw 5:235–242
2. Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F
(2007) Guidelines from the First European Conference on
Infections in Leukaemia: ECIL1 quinolone prophylaxis for bacte-
rial infections in afebrile high risk neutropenic patients. EJC
Supplements 5:5–12
3. Karistinos A, Paulos LE (2007) “Ciprofloxacin-induced”
bilateral rectus femoris tendon rupture. Clin J Sport Med
17:406–407
4. Khaliq Y, Zhanel GG (2003) Fluorochinolon-associated tendinop-
athy: a critical review of the literature. Clin Infect Dis 36:1404–
1410
5. Tanne JH (2008) FDA adds “black box” warning to fluoroquinolone
antibiotics. BMJ 337:a816
 
Fig. 1 Ultrasound of the left supraspinatus tendon. The ultrasound shows
a partial longitudinal rupture of the supraspinatus tendon (white arrows)
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